Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.

People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...

You were diagnosed with CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), a rare autoimmune condition that attacks your body’s nerves, in 2020. How did you process this diagnosis? It’s ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...

Research indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.

Some vitamins and herbal supplements may help to relieve MS symptoms, but others are ineffective and might even be harmful. Learn which is which.

New research suggests that long-distance running triggers a temporary change in brain structure.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Therapies, Medication, Mechanism of Action, Route of Administration by DelveInsight ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...